Lung Carcinoma
92
27
40
27
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.5%
6 terminated out of 92 trials
81.8%
-4.7% vs benchmark
1%
1 trials in Phase 3/4
37%
10 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (92)
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
The Vanguard Study: Testing a New Way to Screen for Cancer
Screening for Lung Cancer in Older Patients (PLCO Screening Trial)
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
Home-Based Respiratory Muscle Training and Aerobic Exercise Programs to Improve Lung Health in Current and Former Cigarette Smokers
Enhanced COPD Management in Suspected Lung Cancer Patients
Testing the SurVaxM Vaccine for Lung Cancer Prevention
Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer
Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial